Acute Leukemia: 177Lu-PentixaTher Treatment

We are testing a new radioligand therapy for patients with relapsed or refractory CXCR4+ acute leukemia. The study aims to evaluate its effectiveness in treating this challenging condition.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire D'Angers
Hématologie
Angers, France
Centre Hospitalier Universitaire D'Angers
Médecine Nucleaire
Angers, France
University Hospital Of Clermont-Ferrand
Médecine Nucleaire
Beaumont, France

Sponsor: Centre Hospitalier Universitaire De Nantes
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.